Cardiac ischemia activates calcium-independent phospholipase A2β, precipitating ventricular tachyarrhythmias in transgenic mice: Rescue of the lethal electrophysiologic phenotype by mechanism-based inhibition

David J. Mancuso, Dana R. Abendschein, Christopher M. Jenkins, Xianlin Han, Jeffrey E. Saffitz, Richard B. Schuessler, Richard W. Gross

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

Murine myocardium contains diminutive amounts of calcium-independent phospholipase A2 (iPLA2) activity (<5% that of human heart), and malignant ventricular tachyarrhythmias are infrequent during acute murine myocardial ischemia. Accordingly we considered the possibility that the mouse was a species-specific knockdown of the human pathologic phenotype of ischemia-induced lethal ventricular tachyarrhythmias. Transgenic mice were generated expressing amounts of iPLA2β activity comparable to that present in human myocardium. Coronary artery occlusion in Langendorff perfused hearts from transgenic mice resulted in a 22-fold increase in fatty acids released into the venous eluent (29.4 nmol/ml in transgenic versus 1.35 nmol/ml of eluent in wild-type mice), a 4-fold increase in lysophosphatidylcholine mass in ischemic zones (4.9 nmol/mg in transgenic versus 1.1 nmol/mg of protein in wild-type mice), and malignant ventricular tachyarrhythmias within minutes of ischemia. Neither normally perfused transgenic nor ischemic wild-type hearts demonstrated these alterations. Pretreatment of Langendorff perfused transgenic hearts with the iPLA2 mechanism-based inhibitor (E)-6-(bromomethylene)-3-(1-naphthalenyl)-2Htetrahydropyran-2-one (BEL) just minutes prior to induction of ischemia completely ablated fatty acid release and lysolipid accumulation and rescued transgenic hearts from malignant ventricular tachyarrhythmias. Collectively these results demonstrate that ischemia activates iPLA2β in intact myocardium and that iPLA2β-mediated hydrolysis of membrane phospholipids can induce lethal malignant ventricular tachyarrhythmias during acute cardiac ischemia.

Original languageEnglish (US)
Pages (from-to)22231-22236
Number of pages6
JournalJournal of Biological Chemistry
Volume278
Issue number25
DOIs
StatePublished - Jun 20 2003
Externally publishedYes

Fingerprint

Calcium-Independent Phospholipase A2
Tachycardia
Transgenic Mice
Phospholipases A2
Ischemia
Phenotype
Myocardium
Fatty Acids
Lysophosphatidylcholines
Coronary Occlusion
Myocardial Ischemia
Hydrolysis
Phospholipids
Coronary Vessels
Membranes

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Cardiac ischemia activates calcium-independent phospholipase A2β, precipitating ventricular tachyarrhythmias in transgenic mice : Rescue of the lethal electrophysiologic phenotype by mechanism-based inhibition. / Mancuso, David J.; Abendschein, Dana R.; Jenkins, Christopher M.; Han, Xianlin; Saffitz, Jeffrey E.; Schuessler, Richard B.; Gross, Richard W.

In: Journal of Biological Chemistry, Vol. 278, No. 25, 20.06.2003, p. 22231-22236.

Research output: Contribution to journalArticle

Mancuso, David J. ; Abendschein, Dana R. ; Jenkins, Christopher M. ; Han, Xianlin ; Saffitz, Jeffrey E. ; Schuessler, Richard B. ; Gross, Richard W. / Cardiac ischemia activates calcium-independent phospholipase A2β, precipitating ventricular tachyarrhythmias in transgenic mice : Rescue of the lethal electrophysiologic phenotype by mechanism-based inhibition. In: Journal of Biological Chemistry. 2003 ; Vol. 278, No. 25. pp. 22231-22236.
@article{e2873ddc0ba0485293a78349737f5ecc,
title = "Cardiac ischemia activates calcium-independent phospholipase A2β, precipitating ventricular tachyarrhythmias in transgenic mice: Rescue of the lethal electrophysiologic phenotype by mechanism-based inhibition",
abstract = "Murine myocardium contains diminutive amounts of calcium-independent phospholipase A2 (iPLA2) activity (<5{\%} that of human heart), and malignant ventricular tachyarrhythmias are infrequent during acute murine myocardial ischemia. Accordingly we considered the possibility that the mouse was a species-specific knockdown of the human pathologic phenotype of ischemia-induced lethal ventricular tachyarrhythmias. Transgenic mice were generated expressing amounts of iPLA2β activity comparable to that present in human myocardium. Coronary artery occlusion in Langendorff perfused hearts from transgenic mice resulted in a 22-fold increase in fatty acids released into the venous eluent (29.4 nmol/ml in transgenic versus 1.35 nmol/ml of eluent in wild-type mice), a 4-fold increase in lysophosphatidylcholine mass in ischemic zones (4.9 nmol/mg in transgenic versus 1.1 nmol/mg of protein in wild-type mice), and malignant ventricular tachyarrhythmias within minutes of ischemia. Neither normally perfused transgenic nor ischemic wild-type hearts demonstrated these alterations. Pretreatment of Langendorff perfused transgenic hearts with the iPLA2 mechanism-based inhibitor (E)-6-(bromomethylene)-3-(1-naphthalenyl)-2Htetrahydropyran-2-one (BEL) just minutes prior to induction of ischemia completely ablated fatty acid release and lysolipid accumulation and rescued transgenic hearts from malignant ventricular tachyarrhythmias. Collectively these results demonstrate that ischemia activates iPLA2β in intact myocardium and that iPLA2β-mediated hydrolysis of membrane phospholipids can induce lethal malignant ventricular tachyarrhythmias during acute cardiac ischemia.",
author = "Mancuso, {David J.} and Abendschein, {Dana R.} and Jenkins, {Christopher M.} and Xianlin Han and Saffitz, {Jeffrey E.} and Schuessler, {Richard B.} and Gross, {Richard W.}",
year = "2003",
month = "6",
day = "20",
doi = "10.1074/jbc.C300033200",
language = "English (US)",
volume = "278",
pages = "22231--22236",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "25",

}

TY - JOUR

T1 - Cardiac ischemia activates calcium-independent phospholipase A2β, precipitating ventricular tachyarrhythmias in transgenic mice

T2 - Rescue of the lethal electrophysiologic phenotype by mechanism-based inhibition

AU - Mancuso, David J.

AU - Abendschein, Dana R.

AU - Jenkins, Christopher M.

AU - Han, Xianlin

AU - Saffitz, Jeffrey E.

AU - Schuessler, Richard B.

AU - Gross, Richard W.

PY - 2003/6/20

Y1 - 2003/6/20

N2 - Murine myocardium contains diminutive amounts of calcium-independent phospholipase A2 (iPLA2) activity (<5% that of human heart), and malignant ventricular tachyarrhythmias are infrequent during acute murine myocardial ischemia. Accordingly we considered the possibility that the mouse was a species-specific knockdown of the human pathologic phenotype of ischemia-induced lethal ventricular tachyarrhythmias. Transgenic mice were generated expressing amounts of iPLA2β activity comparable to that present in human myocardium. Coronary artery occlusion in Langendorff perfused hearts from transgenic mice resulted in a 22-fold increase in fatty acids released into the venous eluent (29.4 nmol/ml in transgenic versus 1.35 nmol/ml of eluent in wild-type mice), a 4-fold increase in lysophosphatidylcholine mass in ischemic zones (4.9 nmol/mg in transgenic versus 1.1 nmol/mg of protein in wild-type mice), and malignant ventricular tachyarrhythmias within minutes of ischemia. Neither normally perfused transgenic nor ischemic wild-type hearts demonstrated these alterations. Pretreatment of Langendorff perfused transgenic hearts with the iPLA2 mechanism-based inhibitor (E)-6-(bromomethylene)-3-(1-naphthalenyl)-2Htetrahydropyran-2-one (BEL) just minutes prior to induction of ischemia completely ablated fatty acid release and lysolipid accumulation and rescued transgenic hearts from malignant ventricular tachyarrhythmias. Collectively these results demonstrate that ischemia activates iPLA2β in intact myocardium and that iPLA2β-mediated hydrolysis of membrane phospholipids can induce lethal malignant ventricular tachyarrhythmias during acute cardiac ischemia.

AB - Murine myocardium contains diminutive amounts of calcium-independent phospholipase A2 (iPLA2) activity (<5% that of human heart), and malignant ventricular tachyarrhythmias are infrequent during acute murine myocardial ischemia. Accordingly we considered the possibility that the mouse was a species-specific knockdown of the human pathologic phenotype of ischemia-induced lethal ventricular tachyarrhythmias. Transgenic mice were generated expressing amounts of iPLA2β activity comparable to that present in human myocardium. Coronary artery occlusion in Langendorff perfused hearts from transgenic mice resulted in a 22-fold increase in fatty acids released into the venous eluent (29.4 nmol/ml in transgenic versus 1.35 nmol/ml of eluent in wild-type mice), a 4-fold increase in lysophosphatidylcholine mass in ischemic zones (4.9 nmol/mg in transgenic versus 1.1 nmol/mg of protein in wild-type mice), and malignant ventricular tachyarrhythmias within minutes of ischemia. Neither normally perfused transgenic nor ischemic wild-type hearts demonstrated these alterations. Pretreatment of Langendorff perfused transgenic hearts with the iPLA2 mechanism-based inhibitor (E)-6-(bromomethylene)-3-(1-naphthalenyl)-2Htetrahydropyran-2-one (BEL) just minutes prior to induction of ischemia completely ablated fatty acid release and lysolipid accumulation and rescued transgenic hearts from malignant ventricular tachyarrhythmias. Collectively these results demonstrate that ischemia activates iPLA2β in intact myocardium and that iPLA2β-mediated hydrolysis of membrane phospholipids can induce lethal malignant ventricular tachyarrhythmias during acute cardiac ischemia.

UR - http://www.scopus.com/inward/record.url?scp=0037929190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037929190&partnerID=8YFLogxK

U2 - 10.1074/jbc.C300033200

DO - 10.1074/jbc.C300033200

M3 - Article

C2 - 12719436

AN - SCOPUS:0037929190

VL - 278

SP - 22231

EP - 22236

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 25

ER -